Jean Chang

Jean Chang has held a series of progressively senior roles in clinical operations in the biotechnology industry. Currently, they serve as the Vice President Clinical Operations at Nanoscope Therapeutics Inc. Prior to this, they were the Executive Director, Clinical Operations at Catalyst Biosciences. Their extensive work experience includes positions at companies such as Adverum Biotechnologies, Trigemina Inc., and MAP Pharmaceuticals. Jean Chang holds a Master of Science (M.S.) degree in Immunology from Wayne State University.